Theranos, Blood-Testing Company Plagued By Scandal, Says It Will Dissolve
The company was once valued at $9 billion. Founder Elizabeth Holmes and another former executive are now facing criminal charges, and Theranos says it does not have the cash to pay shareholders.
by Laurel Wamsley
Sep 05, 2018
2 minutes
Theranos — the Silicon Valley blood-testing startup whose former top executives are accused of carrying out a massive, years-long fraud — is shutting down.
David Taylor, who became CEO in June, said Theranos will dissolve after it attempts to pay creditors with its remaining by , which published .
You’re reading a preview, subscribe to read more.
Start your free 30 days